A light-sensitive targeted anti-tumor prodrug that responds to nitroreductase to kill tumor cells and its preparation method and application
A technology of reaction and reaction solution, which is applied in antineoplastic drugs, drug combinations, organic chemistry, etc., and can solve problems such as high toxicity and side effects, low treatment efficiency, and short half-life
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Add compound 1 (200 mg) into a round bottom flask containing 20 mL of DMF, dissolve completely, add 1.2 equivalents of potassium carbonate solid, dissolve 1.2 equivalents of 4-bromomethylnitrobenzene in 10 mL of DMF, and slowly drop into the bottle , reaction at room temperature for 2h. After the reaction, add 20mL DCM to the bottle, wash with water (7×50mL), take the organic phase and wash with saturated sodium chloride (2×50mL), dry over anhydrous sodium sulfate, filter, and remove the organic solvent by rotary evaporation to obtain the crude product. Compound 2 was separated by thin-layer chromatography, the developer used was D / M=10:1, and the yield was 60%.
Embodiment 2
[0040] The synthesis of embodiment 2 prodrug (CM-3)
[0041] Compound 2 (100 mg) was put into a round-bottomed flask containing 20 mL of DCM. After it was completely dissolved, 2 equivalents of DMAP and 2 equivalents of DCC were added in sequence. After activation for 10 min, 2 times the equivalent of chlorambucil was dissolved in 10 mL of DCM and Pour into the bottle and react overnight. Add 20mL DCM to the bottle, wash with water (7×50mL), wash with saturated sodium chloride (2×50mL), dry over anhydrous sodium sulfate, filter, and rotary evaporate to remove the organic solvent to obtain a crude product, which is separated by thin-layer chromatography to obtain the product CM-3, the developer used is DCM(D) / MeOH(M)=15:1, and the yield is 88%. H NMR spectrum see figure 1 , see C NMR figure 2 .
[0042] 1 H NMR (500MHz, CDCl 3 )δ8.28(d, J=8.7Hz, 2H), 7.63(d, J=8.7Hz, 2H), 7.46(d, J=8.8Hz, 1H), 7.08(d, J=8.6Hz, 2H) ,6.97(dd,J=8.8,2.5Hz,1H),6.91(d,J=2.5Hz,1H),6.64(d,J=8.7...
Embodiment 3
[0043] The synthesis of embodiment 3 prodrugs (CM-3)
[0044] Compound 2 (100 mg) was put into a round bottom flask containing 20 mL of DCM. After it was completely dissolved, 0.1 equivalent of DMAP and 1 equivalent of DCC were added in sequence. After activation for 10 min, 1 equivalent of chlorambucil was dissolved in 10 mL of DCM and Pour into the bottle and react overnight. Add 20mL DCM to the bottle, wash with water (7×50mL), wash with saturated sodium chloride (2×50mL), dry over anhydrous sodium sulfate, filter, and rotary evaporate to remove the organic solvent to obtain a crude product, which is separated by thin-layer chromatography to obtain the product CM-3, the developer used is DCM(D) / MeOH(M)=15:1, and the yield is 53%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com